Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | IVL |
| Upstream (Parents) |
|---|
| (<<) CASP9 → IVL |
| (<<) ELF2 → IVL |
| (<<) GRK5 → IVL |
| (<<) LYPLA2 → IVL |
| (<<) MAP2K3 → IVL |
| (<<) MAP3K9 → IVL |
| (<<) PIK3R5 → IVL |
| (<<) PTGER4 → IVL |
| (<<) RNF111 → IVL |
| (<<) STK4 → IVL |
| (<<) SYNGR4 → IVL |
| (<<) TAF9 → IVL |
| (<<) THRB → IVL |
| (<<) TMPRSS11D → IVL |
| Downstream (Children) |
|---|
| IVL → ADORA2B (>>) |
| IVL → ALPPL2 (>>) |
| IVL → BAALC (>>) |
| IVL → BMPR2 (>>) |
| IVL → CBL (>>) |
| IVL → CCND2 (>>) |
| IVL → CHST12 (>>) |
| IVL → CHST7 (>>) |
| IVL → CREB3L1 (>>) |
| IVL → CTRB2 (>>) |
| IVL → DHRS9 (>>) |
| IVL → DNAJA4 (>>) |
| IVL → DUSP6 (>>) |
| IVL → FZD2 (>>) |
| IVL → GNAQ (>>) |
| IVL → GRB7 (>>) |
| IVL → GSTM3 (>>) |
| IVL → HCN4 (>>) |
| IVL → HDAC3 (>>) |
| IVL → HPS6 (>>) |
| IVL → IL1A (>>) |
| IVL → ISG20 (>>) |
| IVL → KLF7 (>>) |
| IVL → KRT1 (>>) |
| IVL → KRT75 (>>) |
| IVL → LIMK1 (>>) |
| IVL → MAP2K5 (>>) |
| IVL → MAP3K10 (>>) |
| IVL → MERTK (>>) |
| IVL → MLXIPL (>>) |
| IVL → NCOR2 (>>) |
| IVL → PDGFB (>>) |
| IVL → PHOX2A (>>) |
| IVL → PLA2G4A (>>) |
| IVL → PPP2R5C (>>) |
| IVL → PPRC1 (>>) |
| IVL → PTGER1 (>>) |
| IVL → RAD51L3 (>>) |
| IVL → ROCK1 (>>) |
| IVL → RRAS (>>) |
| IVL → RTN3 (>>) |
| IVL → SAA4 (>>) |
| IVL → SMTN (>>) |
| IVL → SPRR1A (>>) |
| IVL → SULT4A1 (>>) |
| IVL → SYNJ2 (>>) |
| IVL → TGFA (>>) |
| IVL → TPM2 (>>) |
| IVL → UTP18 (>>) |
| IVL → WWTR1 (>>) |
